Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model

Spinal muscular atrophy (SMA) is a motor neuron disease and the leading genetic cause of infant mortality. Recently approved SMA therapies have transformed a deadly disease into a survivable one, but these compounds show a wide spectrum of clinical response and effective rescue only in the early sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bersani, Margherita, Rizzuti, Mafalda, Pagliari, Elisa, Garbellini, Manuela, Saccomanno, Domenica, Moulton, Hong M., Bresolin, Nereo, Comi, Giacomo P., Corti, Stefania, Nizzardo, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899506/
https://www.ncbi.nlm.nih.gov/pubmed/34808387
http://dx.doi.org/10.1016/j.ymthe.2021.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899506/
https://www.ncbi.nlm.nih.gov/pubmed/34808387
http://dx.doi.org/10.1016/j.ymthe.2021.11.012

Ejemplares similares